• About Us
  • Privacy Policy
  • Contact
Mortgage Insurance Center
  • Home
  • Mortgages
  • Health Insurance
  • Home Insurance
  • Life insuranace
  • Finance Laws
    • Banking Laws
    • Assets
    • Interest Rate
    • Loans
No Result
View All Result
  • Home
  • Mortgages
  • Health Insurance
  • Home Insurance
  • Life insuranace
  • Finance Laws
    • Banking Laws
    • Assets
    • Interest Rate
    • Loans
No Result
View All Result
Mortgage Insurance Center
No Result
View All Result
Home Banking Laws

Deutsche Bank : DB USA Corporation Pillar 3 report Q1 2022

by Matthew Upton
July 4, 2022
in Banking Laws
0
Ajanta Pharma : Newspaper Advertisements
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

[ad_1]







Deutsche Bank

DB USA Corporation

Pillar 3 Report

as of March 31, 2022

DB USA Corporation

Pillar 3 Report as of March 31, 2022

Contents

INTRODUCTION………………………………………………………………………………………………………………………………………………

3

DISCLOSURES ACCORDING TO PILLAR 3 OF THE BASEL 3 CAPITAL FRAMEWORK ……………………………………………………………………………

3

BASIS OF PRESENTATION …………………………………………………………………………………………………………………………………………..

3

SCOPE OF APPLICATION…………………………………………………………………………………………………………………………………………….

3

RISK AND CAPITAL PERFORMANCE ……………………………………………………………………………………………………………………

4

EXPOSURES AND RISK–WEIGHTED ASSETS………………………………………………………………………………………………………………………..

4

REGULATORY CAPITAL………………………………………………………………………………………………………………………………………………

7

DISCLOSURE OF LIQUIDITY REQUIREMENTS ……………………………………………………………………………………………………………………..

9

2

DB USA Corporation

Pillar 3 Report as of March 31, 2022

Introduction

Disclosures according to Pillar 3 of the Basel 3 Capital Framework

The purpose of this Report is to provide Pillar 3 disclosures for DB USA Corporation (“DB USA Corp”) as required by the regulatory framework for capital & liquidity, established by the Basel Committee on Banking Supervision, also known as Basel 3. Per regulation it is not required to have Pillar 3 disclosures audited. As such the information provided in this Pillar 3 Report is unaudited.

Basis of Presentation

DB USA Corp Pillar 3 Report has been prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”), while Regulatory Capital and Risk Weighted Assets (“RWA”) calculations are based on U.S. Basel 3 Standardized Approach (“U.S. Basel 3”) capital rules. In this regard RWA, Regulatory Capital and associated disclosures are based on U.S. regulatory reporting requirements as defined by the Federal Reserve Bank FR Y-9C Consolidated Financial Statements for Bank Holding Companies (“FR Y-9C”) and in conjunction with U.S. Basel 3 rules. Quantitative Pillar 3 disclosures, in the Pillar 3 Report follow the classification and segmentation required by the FR Y-9C reporting requirements and U.S. Basel 3 guidelines. Where appropriate, we have introduced and modified disclosure tables required by the European Banking Authority (“EBA”), in order to present information consistent with the reporting made in the FR Y-9C and the DB USA Corp audited financial statements, also prepared on a U.S. GAAP basis.

Scope of Application

DB USA Corp is the US Intermediate Holding Company (“IHC”) of Deutsche Bank AG (“DB Group”) that is implemented pursuant to Regulation YY: Enhanced Prudential Standards for Bank Holding Companies and Foreign Banking Organizations, codified in 12 C.F.R. Part 252, and, in particular, Subpart O – Enhanced Prudential Standards for Foreign Banking Organizations with Total Consolidated Assets of $100 Billion or More and Combined U.S. Assets of $100 Billion or More” (the “FBO EPS Rule”). The FBO EPS Rule requires that a foreign banking organization (“FBO”) having combined US assets of $100 billion or more and US non-branch assets of $50 billion or more establish in the US an IHC for its US subsidiaries that must be organized under the applicable US laws and operate under all applicable US regulatory requirements, including leverage and risk-based capital standards, stress testing, risk management and liquidity requirements. DB USA Corp consolidates all of DB Group subsidiaries in the U.S. which include Deutsche Bank Trust Corporation (“DBTC”), Deutsche Bank Trust Company Americas (“DBTCA”), Deutsche Bank Securities Inc. (“DBSI”), Deutsche Bank US Financial Markets Holding Corp. (“DBUSH”), Deutsche Bank Americas Holding Corp. (“DBAH”) and German American Capital Corp. (“GACC”).

3

DB USA Corporation

Pillar 3 Report as of March 31, 2022

Risk and Capital Performance

Exposures and Risk-weighted Assets

DB USA Corp RWA are calculated based on the U.S. Basel 3 Standardized Rules.

The information in the schedules below presents DB USA Corp distribution of RWA by exposure categories as reported in DB USA Corp’s FR Y-9C, Schedule HC-R Regulatory Capital for the period ended March 31, 2022.

Operational Risk RWA is not applicable for banks calculating RWA under the U.S. Basel 3 Standardized Rules.

Market Risk RWA is only applicable to banks that are subject to the Market Risk Final Rule. This rule applies to US banking organizations that have significant trading activity (“Market Risk Banking Organizations”). US Market Risk Banking Organizations have aggregated trading assets and liabilities of at least $1 billion or 10% of total assets. DB USA Corp does meet the definition of a Market Risk Banking Organization and therefore is subject to the Market Risk RWA.

Variance Commentary (2021Q4 to 2022Q1)

The March 2022 On-balance Sheet Exposures decreased $1.2 billion and Off-balance sheet increased $1.3 billion as compared with December 2021 with corresponding impact on RWA increased $2.4 billion. RWA increased despite the net decrease in balance sheet exposures. This was due to the decrease in cash being at 0% risk weight offset mainly by an increase in loans in the 100% and 150% risk weighted buckets and Market Risk RWA due to higher securitized debt exposures.

On -balance Sheet Exposures (decreased $1.2 billion to $120.4 billion):

  • ($7.1) billion decrease in cash and balances due from depository institutions is largely driven by a decrease in deposits of ($6.1 billion) and an increase in loans ($1.2 billion).
  • $3.0 billion increase in security financing transactions driven by an increase in stock borrow balances of $2.5 billion and higher reverse repo balances of $0.5 billion, both within the Investment Bank due to increased client activity.
  • $2.2 billion increase in all other assets driven by higher Fail-to-Deliver balances within the Investment Bank due to a shortage of particular stocks in the market in order to deliver on short sales.

Off -balance Sheet Exposures (increased $1.3 billion to $25.5 billion):

  • $0.7 billion increase in Repo style transactions largely due to the increase in gross balances being with nettable counterparties.
  • $0.7 increase in unsettled transactions driven by an increase in fail to deliver balances.

RWA (increased $2.4 billion to $41.6 billion):

  • $1.4 billion due to higher loans with Private Bank customers ($0.7 billion) and Corporate Bank customers ($0.4 billion) all at 100% risk weight and higher loans with foreign banks ($0.2 billion) at 150% risk weight.
  • $0.2 billion increase from repo style transactions driven by the higher balance sheet.
  • $0.4 billion increase due to unsettled transactions driven by the increase in fail to deliver balances.
  • $0.5 billion increase in Standardized Market RWA is due to higher securitized debt exposures.

4

DB USA Corporation

Pillar 3 Report as of March 31, 2022

Basel 3 Standardized Approach Exposure Amounts by Exposure Class

in USD m.

US Basel 3 Standardized Approach

31-Dec-21

31-Mar-22

Variance

At the end of the

At the end of the

On-balance Sheet Exposures

period

period

Cash and balances due from depository institutions

28,692

21,584

(7,108)

Securities: Available for Sale

1,026

999

(27)

Securities Purchased under agreements to Resell

48,378

51,380

3,002

Loans: Held for Sale

0

0

0

Loans: Residential mortgage exposures

2,598

2,484

(114)

Loans: High volatility commercial real estate exposures

0

0

0

Loans: Exposures past due 90 days or more or on nonaccrual

0

0

0

Loans: All other exposures

10,005

11,353

1,348

Loans: Allowance for Loan Loss

(13)

(15)

(2)

Trading Assets

17,739

17,147

(592)

All Other Assets: All Other

12,341

14,501

2,160

Securitization Exposures: Trading Assets

903

996

93

Total On-balance Sheet Exposures

121,669

120,429

(1,240)

Off-balance Sheet Exposures (credit equivalent amount)

Financial standby letters of credit

691

678

(13)

Performance standby letters of credit

48

46

(2)

Commercial and similar letters of credit

5

0

(5)

Repo style transactions

20,341

20,999

658

Unused commitments: 1 year of less

20

20

0

Unused commitments: exceeding 1 year

2,414

2,148

(266)

Over-the-counter derivatives

229

267

38

Centrally Cleared derivatives

185

301

116

Unsettled Transactions

262

1,018

756

Total Off-balance Sheet Exposures

24,195

25,477

1,282

Figures may include rounding differences.

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Deutsche Bank AG published this content on 04 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 July 2022 11:02:01 UTC.

Publicnow 2022

All news about DEUTSCHE BANK AG

Analyst Recommendations on DEUTSCHE BANK AG

Sales 2022 25 755 M
26 789 M
26 789 M
Net income 2022 3 496 M
3 637 M
3 637 M
Net cash 2022 27 166 M
28 257 M
28 257 M
P/E ratio 2022 5,13x
Yield 2022 3,68%
Capitalization 16 370 M
17 028 M
17 028 M
EV / Sales 2022 -0,42x
EV / Sales 2023 -0,29x
Nbr of Employees 83 000
Free-Float 92,8%



Duration :


Period :




Deutsche Bank AG Technical Analysis Chart | MarketScreener

Technical analysis trends DEUTSCHE BANK AG

Short Term Mid-Term Long Term
Trends Bearish Bearish Bearish



Income Statement Evolution

Sell

Buy

Mean consensus HOLD
Number of Analysts 19
Last Close Price 8,05 €
Average target price 12,60 €
Spread / Average Target 56,4%


[ad_2]

Source link

Previous Post

Novacap announces sale of Greenwood Mushrooms Development Corp to Instar Asset Management Inc

Next Post

How Much Do Interest Rates Help?

Next Post
How Much Do Interest Rates Help?

How Much Do Interest Rates Help?

Popular Posts

Ajanta Pharma : Newspaper Advertisements
Life insuranace

Taiming Assurance Broker : Announcement on behalf of the major subsidiary Link-Aim Life Insurance Broker Co.,LTD. to distribute dividends.

by Matthew Upton
July 28, 2022
0

Close Provided by: TAIMING ASSURANCE BROKER CO.,LTD. SEQ_NO 4 Date of...

Read more

Taiming Assurance Broker : Announcement on behalf of the major subsidiary Link-Aim Life Insurance Broker Co.,LTD. to distribute dividends.

20% interest rate on credit cards! Here’s how to avoid paying those high rates :: WRAL.com

Sens. Murphy, Blumenthal, Colleagues Reintroduce the Behavioral Health Coverage Transparency Act – InsuranceNewsNet

$1 billion in loans still available for agricultural funding in Ohio

How Long Do Car Accidents Stay on Your Record?

Rocket Mortgage Classic Wagers: Pick To Finish Top-10

Load More

Popular Posts

Hingham DPW Workers Deserve Respect, Decent Wages and Affordable Health Insurance

Hingham DPW Workers Deserve Respect, Decent Wages and Affordable Health Insurance

by Matthew Upton
July 5, 2022
0

Propy introduces blockchain title and escrow service

Propy introduces blockchain title and escrow service

by Matthew Upton
May 26, 2022
0

Biden administration sued after fertility awareness methods cut from health coverage

by Matthew Upton
June 15, 2022
0

Ajanta Pharma : Newspaper Advertisements

Taiming Assurance Broker : Announcement on behalf of the major subsidiary Link-Aim Life Insurance Broker Co.,LTD. to distribute dividends.

July 28, 2022

20% interest rate on credit cards! Here’s how to avoid paying those high rates :: WRAL.com

July 28, 2022
Edelweiss General Insurance launches India’s first on-demand, mobile telematics-based comprehensive motor insurance – SWITCH

Sens. Murphy, Blumenthal, Colleagues Reintroduce the Behavioral Health Coverage Transparency Act – InsuranceNewsNet

July 28, 2022

Categories

  • Assets
  • Banking Laws
  • Finance Laws
  • Health Insurance
  • Home Insurance
  • Interest Rate
  • Life insuranace
  • Loans
  • Mortgages

Tags

home loans mortgage personal loan
  • Privacy Policy
  • contact us

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • About Us
  • contact us
  • Home
  • Home 2
  • Home 3
  • Privacy Policy

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.